Pricing Log in Create free account

MediWound Ltd. (MDWD) vs Upstream Bio, Inc. (UPB)

MediWound Ltd. and Upstream Bio, Inc. are both Biotechnology companies. MediWound Ltd. and Upstream Bio, Inc. are of similar size ($184.0M and $176.9M). Upstream Bio, Inc. grew revenue faster over the last twelve months: 16.0% against −40.3%. MediWound Ltd. has the higher net margin (−170.1% vs −4,955.7%) and the lower return on invested capital (−6,551.8% vs −1,100.9%). Across the 16 metrics below, Upstream Bio, Inc. leads on 9 and MediWound Ltd. on 7.

Valuation

Metric MDWD UPB Biotechnology median
P/E n/m n/m 10.60
P/S 15.48 55.81 9.40
P/B 5.15 0.65 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.50 0.66
EV/Sales 12.58 (26.93) 9.02
Earnings yield (11.23%) (89.78%) (32.88%)
Free cash flow yield (15.56%) (77.55%) (23.13%)

Profitability

Metric MDWD UPB Biotechnology median
Gross margin 15.46% 100.00% 68.51%
Operating margin (267.75%) (5,382.65%) 0.00%
Net margin (170.10%) (4,955.67%) 0.00%
Free cash flow margin (240.47%) (4,317.42%) 0.00%
Return on equity (75.42%) (46.05%) (51.96%)
Return on assets (29.06%) (44.61%) (46.06%)
Return on invested capital (6,551.77%) (1,100.93%) 0.00%

Growth

Metric MDWD UPB Biotechnology median
Revenue growth (TTM) (40.26%) 15.98% 6.76%
EPS growth (last fiscal year) 30.69% 52.33% 29.88%
Revenue growth, 5-year CAGR (4.87%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MDWD UPB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 27.99 4.97
Net debt to EBITDA 2.27 2.11 1.01

Dividend

Metric MDWD UPB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MDWD UPB Biotechnology median
Market cap 183.97m 176.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack